We retrospectively investigated the predictive value of lymphocyte subset changes in the peripheral blood of 37 consecutive liver transplant recipients for rejection and infection, both bacterial and cytomegalovirus, during a period of 2 years. Total lymphocyte count correlated with biopsy-proven rejection. There was moderate elevation of CD16+ count during the course of bacterial infection.
Get full access to this article
View all access options for this article.
References
1.
BrunP, SterkersG, MaisinA, . Flow-cytometry monitoring of antilymphocyte globulin therapy in pediatric renal transplantation.Transplant Proc1995;27:1744–5.
2.
MorrisPJ, CarterNP, CullenPR, . Role of T cell subsets monitoring in renal allograft recipients.N Engl J Med1982;306:1110–1.
3.
ShanahanT.Application of flow cytometry in transplantation medicine.Immunol Invest1997;26:91–101.
4.
CosimiAB, ColvinRB, BurtonRC, . Use of monoclonal antibodies to T-cell subsets for immunological monitoring and treatment in recipients of renal allografts.N Engl J Med1981;305:308–14.
5.
RewDA.Clinical applications of flow cytometry.Br J Hosp Med1992;48:171–5.
6.
GuttmannRD.Clinical immunosuppression, lymphocyte subsets, and host defence mechanisms.Transplant Proc1994;26: 1847.
7.
BrayRA.Flow cytometry in the transplant laboratory.Ann NY Acad Sci1993;677:138–51.
8.
MathurA, KamatDM, FilipovichAH, . Immunoregulatory abnormalities in patients with Epstein-Barr virus-associated B cell lymphoproliferative disorders.Transplantation1994;57:1042–55.
9.
KhanujaPS, Toledo-PereyraLH, GordonDA, . Contribution of T-cell subset monitoring of renal transplant recipients in the cyclosporine era.Transplant Proc1989;21:1852–3.
10.
BuchmanTE, KershawDB, MerionRM, . T cell subset analysis by flow cytometry during MALG induction for pediatric renal transplantation.Transplantation1993;55:1190–3.
11.
EllisTM, BerryCR, Mendez-PiconG, . Immunological monitoring of renal allograft recipients using monoclonal antibodies to human T lymphocyte subpopulations.Transplantation1982;33:317–9.
12.
Centers for Disease Control and Prevention.Recommendations and Reports: Revised Guidelines for the Performance of CD4+ T-Cell Determinations in Persons with Human Immunodeficiency Virus (HIV) Infection.MMWR Morbid Mortal Wkly Rev1994;43(RR-3):1–21.
13.
KotyloPK.Rapid analysis of lymphocyte subsets in cord blood.Am J Clin Pathol1993;19:263–6.
14.
MutimerD, Mayti-TothA, ShawJ, . Patterns of viremia in liver transplant recipients with symptomatic cytomegalovirus infection.Transplantation1997;63:68–73.
15.
TrinidadeH, da CostaAG, LimaCA, . Lymphocyte populations in peripheral blood after kidney transplantation.Transplant Proc1992;24:2553–5.
16.
ReinkeP, FietzeE, DockeW-D, . Late acute rejection in long-term renal allograft recipients: Diagnostic and predictive value of circulating activated T cells.Transplantation1994;58:35–41.
17.
RobertiI, ReismanL, BurrowsL, LiebermanKV.Urine cytology and urine flow cytometry in renal transplantation: A prospective double blind study.Transplantation1995;59:495–500.
18.
SalcedoM, HoglundP, LjungrenH-G.Natural killer cell interaction with murine allogeneic MHC class I molecules.Transplantation1995;60:281–6.
19.
KutukculerN, ClarkK, RiggKM, . The value of posttransplant monitoring of interleukin (IL)-2, IL-3, IL-4, IL-6, IL-8, and soluble CD23 in the plasma of renal allograft recipients.Transplantation1995;59:333–40.
20.
NikaeinA, AlivizatosPA, MonahanK, StoneMJ.The role of anti-class II HLA antibodies in heart transplantation.Transplantation1995;59:439–42.
HayryPJ.Fine needle aspiration biopsy in renal transplantation.Kidney Int1989;36:130–41.
23.
BaegrRV, VolkH-D, ReinkeP, . An immune monitoring program for controlling immunosuppressive therapy.Transplant Proc1989;21:1189–91.
24.
MulukSC, ClericiM, ViaCS, . Correlation of in vitro CD4+ T helper cell function with clinical graft status in immuno-suppressed kidney transplant recipients.Transplantation1991;52:284–91.
